Factors such as not achieving your goal weight loss, having side effects you can't tolerate, or experiencing rare but serious medication reactions are reasons to stop taking the medicine
But that is very different from saying the medication itself is a proven Alzheimers-prevention therapy
On the other hand, Structure Therapeutics is a clinical-stage biotech firm evaluating several obesity drugs in clinical and preclinical studies
Over 60 companies are now developing GLP-1 drugs, including heavyweights like Pfizer and Amgen, alongside agile biotechs like Viking Therapeutics
Our editorial team sees Piper as a higher-risk option in the current GLP-1 telehealth landscape
ZP CON BS 25FEB2026 Zepbound , its delivery device base and KwikPen are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates